Addex Therapeutics Ltd (SWX:ADXN)
0.0578
+0.0020 (3.58%)
Sep 5, 2025, 5:30 PM CET
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of 5.68 million as of September 5, 2025. Its market cap has increased by 9.93% in one year.
Market Cap
5.68M
Enterprise Value
2.90M
Revenue
246.19K
Ranking
n/a
PE Ratio
0.66
Stock Price
0.06
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from 398.65M to 5.68M, a decrease of -98.57%. That is a compound annual growth rate of -20.72%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 4, 2025 | 5.49M | -2.42% |
Dec 30, 2024 | 5.62M | -9.01% |
Dec 29, 2023 | 6.18M | -40.48% |
Dec 30, 2022 | 10.39M | -73.65% |
Dec 30, 2021 | 39.42M | -25.96% |
Dec 30, 2020 | 53.24M | 22.57% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 237.12B |
Novartis AG | 201.29B |
Lonza Group AG | 40.61B |
Galderma Group AG | 33.64B |
Alcon | 31.68B |
Sandoz Group AG | 21.05B |
Straumann Holding AG | 15.14B |
Sonova Holding AG | 14.16B |